Citadel Advisors
BCPC

Citadel Advisors’s Balchem Corp BCPC Stock Holding History

Citadel Advisors’s Portfolio BCPC Stock Details BCPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$203K Buy
+1,200
New +$204K ﹤0.01% 11392
2025
Q2 		– Sell
-300
Closed -$49.8K – 15730
2025
Q1 		$49.8K Buy
300
+200
+200% +$32.8K ﹤0.01% 12318
2024
Q4 		$16.3K Hold
100
– – ﹤0.01% 13311
2024
Q3 		$17.6K Hold
100
– – ﹤0.01% 12875
2024
Q2 		$15.4K Sell
100
-1,600
-94% -$241K ﹤0.01% 12833
2024
Q1 		$263K Buy
1,700
+1,400
+467% +$208K ﹤0.01% 9750
2023
Q4 		$44.6K Sell
300
-100
-25% -$12.8K ﹤0.01% 11904
2023
Q3 		$49.6K Buy
400
+200
+100% +$26.6K ﹤0.01% 11770
2023
Q2 		$27K Sell
200
-100
-33% -$12.9K ﹤0.01% 12463
2023
Q1 		$37.9K Buy
300
+200
+200% +$25.9K ﹤0.01% 12482
2022
Q4 		$12.2K Buy
+100
New +$13.2K ﹤0.01% 13521
2022
Q2 		– Sell
-2,100
Closed -$287K – 14325
2022
Q1 		$287K Buy
+2,100
New +$301K ﹤0.01% 10697
2021
Q4 		– Sell
-1,600
Closed -$232K – 14956
2021
Q3 		$232K Buy
+1,600
New +$217K ﹤0.01% 11655

Other funds holding BCPC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors's BCPC Position: Q1 2026 in Review

Citadel Advisors increased its Balchem Corp (BCPC) stake by 103% in Q1 2026, buying an estimated $1.79M and bringing the position to 20,688 shares worth $3.51M. The position accounts for ﹤0.01% of the portfolio, ranked #4954.

Citadel Advisors first reported a position in BCPC in Q4 2013 and has held it in 36 quarters since. The position peaked at $13M in Q2 2025. 422 funds tracked by Wall St. Rank hold BCPC as of Q1 2026.

  • Citadel Advisors held 20,688 shares of Balchem Corp worth $3.51M as of Q1 2026.
  • Citadel Advisors bought 10,512 Balchem Corp shares in Q1 2026, an estimated $1.79M.
  • Balchem Corp made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4954 holding.
  • Citadel Advisors first reported a position in Balchem Corp in Q4 2013 and has held it in 36 quarters since.
  • Citadel Advisors's Balchem Corp position peaked at $13M in Q2 2025.
  • 422 funds tracked by Wall St. Rank held Balchem Corp as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.